Max Healthcare Institute Limited has informed the Exchange regarding grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare Institute's Nomination and Remuneration Committee approved the grant of 2,15,000 stock options to eligible employees under the company's ESOP scheme 2022. The options are split into two tranches: 90,000 options at ₹350 per option and 1,25,000 options at ₹800 per option. Each option converts into one fully paid-up equity share with face value of ₹10. The vesting period ranges from 1 to 5 years from the grant date, with an exercise window of 3 years from vesting. The scheme complies with SEBI's Share Based Employee Benefits Regulations, 2021.
The ESOP grant aligns employee interests with shareholders and aids talent retention. However, it creates potential dilution of 2,15,000 equity shares if all options are exercised. The impact on stock price is likely neutral to slightly negative due to dilution concerns, though the incentive structure may boost long-term performance.